Shield Bio
InactiveBringing 3rd generation, nanopore sequencing to healthcare to solve…
What it does
Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.
Next to it in Healthcare and bio · nanopore sequencing diagnostics
- Kenota (formerly ExVivo Labs)Y Combinator S16
Kenota is revolutionizing the way we test for disease
- Loop GenomicsY Combinator W16
Novel long-read DNA sequencing technology
- Luminist LabsY Combinator W16
Diagnostic platform for early detection of liver disease
- mFluiDXSOSV SOSV IndieBio 03
Enabling molecular detection anywhere
- DeleeY Combinator W17
Blood testing device for early diagnosis of cancer and treatment…
- InnaMedY Combinator W17
At-home blood testing: measure + analyze + enhance.
- ACCELStars, Inc.Plug and Play
The University of Tokyo Medical! Sleep with the world's highest accuracy with arm-mounted equipment-Captures awakening, and discover, treat, and prevent brain and mental illness. / 東大医発！腕装着機器で世界最高精度の技術で睡眠-覚醒を捉え、脳と心の病気等を早期発見・治療・予防する
- AiporePlug and Play
Aipore is a technology company specializing in the area of nanopore sensor using semiconductor Si microfabrication technology.